TrialGene therapy2001
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
S Mulvihill et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
102 papers cite itlatest 60 shown
this paperpooled ittrialcites it